Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TOBI PODHALER BGP PHARMA ULC Actual shortage 28MG Updated Report 2024-11-04 236492
CLARUS MYLAN PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2024-11-04 241465
MYLAN-CLOBETASOL CREAM MYLAN PHARMACEUTICALS ULC Actual shortage 0.05% Updated Report 2024-11-04 230115
MYLAN-ESCITALOPRAM MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2024-11-04 236497
MYLAN-GLICLAZIDE MR MYLAN PHARMACEUTICALS ULC Actual shortage 30MG Updated Report 2024-11-04 240838
MYLAN-HYDROXYUREA MYLAN PHARMACEUTICALS ULC Actual shortage 500MG Updated Report 2024-11-04 238425
MYLAN-MIRTAZAPINE MYLAN PHARMACEUTICALS ULC Actual shortage 15MG Updated Report 2024-11-04 232547
MYLAN-MIRTAZAPINE MYLAN PHARMACEUTICALS ULC Actual shortage 45MG Updated Report 2024-11-04 230092
MYLAN-VARDENAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2024-11-04 228366
MYLAN-VARDENAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2024-11-04 228378

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
DORZOLAMIDE AND TIMOLOL EYE DROPS BP HIKMA CANADA LIMITED Discontinued 5MG 20MG New Report 2024-11-01 241852
PEDIACEL SANOFI PASTEUR LIMITED Discontinued 5MCG 20MCG 30MCG 10MCG 26UNIT 7UNIT 29UNIT 5LF 15LF 20MCG 3MCG New Report 2024-11-01 241815
DALACIN C 300 MG PFIZER CANADA ULC Discontinued 300MG Updated Report 2024-10-30 241493
PANTOPRAZOLE SODIUM FOR INJECTION SANDOZ CANADA INCORPORATED Discontinued 40MG New Report 2024-10-29 241520
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-10-29 224347
IMDUR JUNO PHARMACEUTICALS CORP. Discontinued 60MG Updated Report 2024-10-29 233587
TD ADSORBED SANOFI PASTEUR LIMITED Discontinued 5LF 2LF Updated Report 2024-10-25 206909
HUMATROPE ELI LILLY CANADA INC To be discontinued 24MG 3.15ML New Report 2024-10-18 240682
HUMATROPE ELI LILLY CANADA INC To be discontinued 12MG 3.15ML New Report 2024-10-18 240679
HUMATROPE ELI LILLY CANADA INC To be discontinued 6MG 3.15ML New Report 2024-10-18 240676
PEDIACEL SANOFI PASTEUR LIMITED To be discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-10-15 206912
VICTOZA NOVO NORDISK CANADA INC To be discontinued 6MG New Report 2024-10-15 240246
XULTOPHY NOVO NORDISK CANADA INC To be discontinued 3.6MG 100UNIT New Report 2024-10-15 240243
FIASP NOVO NORDISK CANADA INC To be discontinued 100UNIT New Report 2024-10-15 240240
NOVOLIN GE 30/70 PENFILL NOVO NORDISK CANADA INC To be discontinued 70UNIT 30UNIT New Report 2024-10-15 240237
NOVOLIN GE NPH PENFILL NOVO NORDISK CANADA INC To be discontinued 100UNIT New Report 2024-10-15 240234
LEVEMIR PENFILL NOVO NORDISK CANADA INC To be discontinued 100UNIT New Report 2024-10-15 240231
NOVOLIN GE TORONTO PENFILL NOVO NORDISK CANADA INC To be discontinued 100UNIT New Report 2024-10-15 240227
TEVA-MIRTAZAPINE TEVA CANADA LIMITED Discontinued 30MG New Report 2024-10-11 240081
TEVA-OXYBUTYNIN TEVA CANADA LIMITED Discontinued 5MG New Report 2024-10-11 240078